📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders. (2022)

First Author: Damato V

Attributed to: Characterisation of autoantigen-specific human B cells in central nervous system autoantibody-mediated diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1073/pnas.2121804119

PubMed Identifier: 35666871

Publication URI: http://europepmc.org/abstract/MED/35666871

Type: Journal Article/Review

Volume: 119

Parent Publication: Proceedings of the National Academy of Sciences of the United States of America

Issue: 24

ISSN: 0027-8424